NFE2L2 and cardiomyopathy: These results demonstrate that Dox treatment activates Nrf2 in the heart, thus supporting the notion that Nrf2 activation serves as a feedback mechanism to suppress Dox-induced cardiomyopathy by suppression of oxidative stress and enhancement of autophagic clearance of toxic protein aggregates.